ABSTRACT
Supervised exercise therapy (SET) is an effective intervention for symptomatic peripheral artery disease. Its effect on metabolism, measured by the circulating metabolome is not well understood. Participants underwent the Gardner graded treadmill test before and after SET and blood was sampled before and after each treadmill test. We tested the average association of metabolite levels with timing of blood draws. We used five models to identify metabolites or changes in metabolites at specific time points that associate with treadmill test performance or inter-individual variability in functional performance after SET. When analyzing individual time points, high levels of anandamide (AEA) before any exercise interventions were associated with shorter, or worse, walking time. Increased arachidonic acid (AA) and decreased levels of AA precursors (dihomo-γ-linolenic acid and diacylglycerol) before any exercise was associated with shorter walking times. Participants who tolerated large increases in AA during acute exercise had longer, or better, walking times before and after SET. We identified two pathways of relevance to individual response to SET: AEA synthesis may increase the activity at endocannabinoid receptors, resulting in worse treadmill test performance. SET may help train patients withstand higher levels of AA and inflammatory signaling, resulting in longer walking times.
Competing Interest Statement
S.M.D. receives research support to his institution from CytoVAS, LLC and RenalytixAI and consulting fees from Calico Labs, all outside the scope of the current work. All other authors have no conflicts of interest to declare.
Clinical Trial
Data was obtained from a previously published clinical trial NCTID 2RO1HL075649-06A2.
Funding Statement
This research supported by NIH NCATS UL1TR000003. S.M.D was also supported by funding from the Department of Veterans Affairs IK2-CD001780. The authors wish to thank patient participants; without their assistance, this research would not have been possible. This publication does not represent the views of the Department of Veterans Affairs, the US Food and Drug Administration, or the US Government.
Author Declarations
I confirm all relevant ethical guidelines have been followed, and any necessary IRB and/or ethics committee approvals have been obtained.
Yes
The details of the IRB/oversight body that provided approval or exemption for the research described are given below:
The study was reviewed by the University of Pennsylvania Institutional Review Board for Human Subjects Research. All participants provided written informed consent prior to inclusion in this study: NCTID 2RO1HL075649-06A2.
All necessary patient/participant consent has been obtained and the appropriate institutional forms have been archived.
Yes
I understand that all clinical trials and any other prospective interventional studies must be registered with an ICMJE-approved registry, such as ClinicalTrials.gov. I confirm that any such study reported in the manuscript has been registered and the trial registration ID is provided (note: if posting a prospective study registered retrospectively, please provide a statement in the trial ID field explaining why the study was not registered in advance).
Yes
I have followed all appropriate research reporting guidelines and uploaded the relevant EQUATOR Network research reporting checklist(s) and other pertinent material as supplementary files, if applicable.
Yes
Data Availability
Additional data that were used to generate the Figures in this study are available on request from the corresponding author (S.M.D.)